12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Thursday's intraday session, several healthcare stocks experienced significant movements. Yield10 Bioscience (YTEN) saw a 104.4% increase, while Solid Biosciences (SLDB) rose by 54.67%. Kewaunee Scientific (KEQU) increased by 29.89% following their Q2 earnings release. G1 Therapeutics (GTHX), Know Labs (KNW), and Universe Pharmaceuticals (UPC) also saw gains. Conversely, Phio Pharma (PHIO), WAVE Life Sciences (WVE), Kineta (KA), Kintara Therapeutics (KTRA), Brainstorm Cell (BCLI), and Concord Medical Services (CCM) experienced declines.
December 07, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
G1 Therapeutics stock increased by 22.1% to $2.96, with a market cap of $153.1 million.
The rise in G1 Therapeutics' stock price may reflect positive market sentiment or recent company developments that have attracted investor interest.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Kewaunee Scientific's stock rose 29.89% to $22.9 following their Q2 earnings release, with a market cap of $66.5 million.
The positive reaction to the Q2 earnings report suggests that the results were better than expected, leading to increased investor confidence.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Know Labs shares increased 19.55% to $0.56, with a market cap of $44.8 million.
The stock's gain could be attributed to investor actions based on company news or broader market trends affecting the sector.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Solid Biosciences stock jumped 54.67% to $5.29, with a market cap of $106.7 million.
The significant increase in stock price could be due to recent company achievements or positive investor sentiment in the biotech sector.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Universe Pharmaceuticals shares rose 19.13% to $1.37, with a market cap of $4.9 million.
The increase in Universe Pharmaceuticals' share price may be driven by sector-specific investor interest or company-specific news.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Yield10 Bioscience shares soared 104.4% to $0.46, with a market cap of $5.4 million.
The substantial rise in stock price indicates strong investor interest, potentially due to positive developments within the company or favorable market conditions for their sector.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Brainstorm Cell stock fell 17.6% to $0.24, with a market cap of $12.0 million.
The decline in Brainstorm Cell's stock price might be due to negative clinical results, financial reports, or investor sentiment.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Concord Medical Services stock fell 16.54% to $0.93, with a market cap of $40.2 million.
The drop in Concord Medical Services' stock could be related to company-specific issues or negative trends in the healthcare sector.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Kineta stock declined by 27.8% to $3.17, with a market cap of $32.9 million.
The decrease in Kineta's stock price may reflect investor concerns or adverse events affecting the company's outlook.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Kintara Therapeutics stock decreased by 18.64% to $0.23.
Kintara Therapeutics' stock decline could be due to negative news or bearish market sentiment towards the company.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Phio Pharma shares fell 40.3% to $0.95, with a market cap of $2.3 million.
The sharp decline in Phio Pharma's stock price suggests negative investor sentiment or disappointing company news.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
WAVE Life Sciences stock dropped 30.21% to $4.79, with a market cap of $474.9 million.
The significant drop in WAVE Life Sciences' stock price could indicate market reactions to negative developments or broader industry downturns.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100